Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
124 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01735955 | Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study | completed | Phase 4 | 57 | Novartis PharmaceuticalsINDUSTRY | 16 | Feb 8, 2024 | clinicaltrials |
| NCT03432949 | Radium-223 Combined With Dexamethasone as First-line Therapy in Patients With M+CRPC(TRANCE) | unknown | Phase 4 | 24 | University Health Network, TorontoOTHER | 1 | Jan 24, 2024 |
| clinicaltrials |
| NCT03410836 | Impact of Intravenous Lidocaine During Colorectal Surgery on Pain and Immune Functions | unknown | Phase 4 | 60 | Ciusss de L'Est de l'Île de MontréalOTHER | 1 | Oct 18, 2023 | clinicaltrials |
| NCT02869789 | An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers | completed | Phase 4 | 1,041 | Bristol-Myers SquibbINDUSTRY | 21 | Jun 15, 2023 | clinicaltrials |
| NCT04769713 | Hepatic Hilar Nerve Block Versus Sham in Pain Control During Liver Ablation and TACE Procedures | unknown | Phase 4 | 80 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Jun 2, 2023 | clinicaltrials |
| NCT02032953 | Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia | unknown | Phase 4 | 24 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Mar 17, 2023 | clinicaltrials |
| NCT03145012 | Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity | completed | Phase 4 | 30 | Nova Scotia Health AuthorityOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT01436292 | Hypoalbuminemia in Burn Patients(Halburns) | withdrawn | Phase 4 | 0 | Centre hospitalier de l'Université de Montréal (CHUM)OTHER | 1 | Nov 17, 2022 | clinicaltrials |
| NCT03948568 | Evaluating Optimal Timing of Endocrine Therapy and Radiation Therapy in Early-stage Breast Cancer (REaCT-RETT)(REaCT-RETT) | completed | Phase 4 | 262 | Ottawa Hospital Research InstituteOTHER | 1 | Sep 30, 2022 | clinicaltrials |
| NCT02476968 | To Assess the Efficacy and Safety of Olaparib Maintenance Monotherapy in the Treatment of Ovarian Cancer(ORZORA) | completed | Phase 4 | 181 | AstraZenecaINDUSTRY | 8 | Sep 10, 2022 | clinicaltrials |
| NCT02447718 | Vaccinating Children After Chemotherapy | completed | Phase 4 | 156 | Canadian Immunization Research NetworkNETWORK | 1 | Jun 24, 2022 | clinicaltrials |
| NCT04479579 | Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery | completed | Phase 4 | 53 | McMaster UniversityOTHER | 1 | Apr 22, 2022 | clinicaltrials |
| NCT03727750 | Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML | completed | Phase 4 | 51 | PfizerINDUSTRY | 6 | Mar 25, 2022 | clinicaltrials |
| NCT04864717 | Doxycycline vs Isotretinoin for Acneiform Eruptions of TKI | unknown | Phase 4 | 98 | Lady Davis InstituteOTHER | 1 | Sep 8, 2021 | clinicaltrials |
| NCT02275702 | Randomized Study of Preoperative Dexamethasone for Quality of Recovery in VATS Lung Resection Patients(APV) | completed | Phase 4 | 100 | Laval UniversityOTHER | 1 | Aug 25, 2021 | clinicaltrials |
| NCT02092467 | Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis | completed | Phase 4 | 4,372 | PfizerINDUSTRY | 30 | Aug 17, 2021 | clinicaltrials |
| NCT01413607 | The Use of Self Retaining Sutures in Open and Laparoscopic Partial Nephrectomy | terminated | Phase 4 | 65 | Ricardo RendonOTHER | 1 | Aug 2, 2021 | clinicaltrials |
| NCT00980018 | An Exploratory Trial to Assess the Improvement of Adverse Events in Chronic Myelogenous Leukemia Patients Treated With Imatinib When Switched to Nilotinib Treatment(MACS0999) | completed | Phase 4 | 52 | Novartis PharmaceuticalsINDUSTRY | 2 | Jul 1, 2021 | clinicaltrials |
| NCT04907812 | The Role of Tranexamic Acid in Reducing Post Operative Hand Edema After Hand and Wrist Surgery(THAW) | unknown | Phase 4 | 50 | Ruby GrewalOTHER | 1 | Jun 1, 2021 | clinicaltrials |
| NCT01953107 | Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. | completed | Phase 4 | 200 | Sunnybrook Health Sciences CentreOTHER | 1 | May 12, 2021 | clinicaltrials |
| NCT02472249 | Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC | completed | Phase 4 | 10 | University Health Network, TorontoOTHER | 1 | Apr 28, 2021 | clinicaltrials |
| NCT03738527 | SEroma Reduction pOst MAstectomy "SEROMA Study"(SEROMA) | unknown | Phase 4 | 100 | Hamilton Health Sciences CorporationOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT02624349 | Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients | completed | Phase 4 | 37 | The Hospital for Sick ChildrenOTHER | 1 | Feb 15, 2021 | clinicaltrials |
| NCT03215355 | Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium | withdrawn | Phase 4 | 0 | Slawa CwajnaOTHER | 1 | Jan 27, 2021 | clinicaltrials |
| NCT00381095 | A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer(COPE) | terminated | Phase 4 | 152 | Pfizer's Upjohn has merged with Mylan to form Viatris Inc.INDUSTRY | 19 | Jan 20, 2021 | clinicaltrials |
| NCT01739764 | An Extension (Rollover) Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Malignancies Previously Enrolled in an Antecedent Vemurafenib Protocol | completed | Phase 4 | 215 | Hoffmann-La RocheINDUSTRY | 25 | Jan 7, 2021 | clinicaltrials |
| NCT02721433 | 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases(REaCT-BTA) | completed | Phase 4 | 263 | Ottawa Hospital Research InstituteOTHER | 1 | Dec 2, 2020 | clinicaltrials |
| NCT01588184 | An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study | completed | Phase 4 | 95 | Hoffmann-La RocheINDUSTRY | 21 | Nov 5, 2020 | clinicaltrials |
| NCT02816112 | Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia(REaCT-TC2) | completed | Phase 4 | 458 | Ottawa Hospital Research InstituteOTHER | 1 | May 27, 2020 | clinicaltrials |
| NCT02815319 | Schedules of Dexamethasone in Patients Incorrectly Taking Dexamethasone Premedication (REaCT-dexamethasone)(REaCT-dex) | completed | Phase 4 | 60 | Ottawa Hospital Research InstituteOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT03969108 | Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment | completed | Phase 4 | 10 | University Health Network, TorontoOTHER | 1 | Mar 27, 2020 | clinicaltrials |
| NCT03348696 | Comparing Tapering Low Dose Dexamethasone to Other Standard of Care Therapies for TAPS in Breast Cancer Patients(REaCT-TAPS) | completed | Phase 4 | 124 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 9, 2020 | clinicaltrials |
| NCT01578213 | Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients(ISAV) | completed | Phase 4 | 112 | University of Milano BicoccaOTHER | 5 | Dec 3, 2019 | clinicaltrials |
| NCT00858754 | Study Evaluating Safety & Efficacy of Subcutaneous Methylnaltrexone on Opioid-Induced Constipation in Cancer Subjects | withdrawn | Phase 4 | 0 | Bausch Health Americas, Inc.INDUSTRY | 4 | Nov 29, 2019 | clinicaltrials |
| NCT01512472 | Firmagon (Degarelix) Intermittent Therapy(FIT) | terminated | Phase 4 | 144 | Canadian Urology Research ConsortiumOTHER | 1 | Sep 23, 2019 | clinicaltrials |
| NCT02816164 | A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia(REaCT-G2) | completed | Phase 4 | 324 | Ottawa Hospital Research InstituteOTHER | 1 | Sep 6, 2019 | clinicaltrials |
| NCT01189409 | Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients | terminated | Phase 4 | 70 | British Columbia Cancer AgencyOTHER | 1 | Aug 28, 2019 | clinicaltrials |
| NCT02818816 | Preoperative Brimonidine on IOP of Patients Undergoing RALP(IOPsTBURG) | completed | Phase 4 | 26 | University Health Network, TorontoOTHER | 1 | Sep 27, 2018 | clinicaltrials |
| NCT02173262 | REaCT Integrated Consent Model to Compare Two Standard of Care Regimens(OTT14-03) | completed | Phase 4 | 142 | Ottawa Hospital Research InstituteOTHER | 1 | Nov 6, 2017 | clinicaltrials |
| NCT00179478 | Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis(CHAMPIONS10) | completed | Phase 4 | 155 | Beth Israel Deaconess Medical CenterOTHER | 2 | Sep 6, 2017 | clinicaltrials |
| NCT01907880 | The ODYSSEY TRIAL Phase IV Trial Evaluating the Palliative Benefit of Pamidronate or Zoledronic Acid in Breast Cancer(ER11-03) | completed | Phase 4 | 74 | Ottawa Hospital Research InstituteOTHER | 1 | Jul 7, 2017 | clinicaltrials |
| NCT01230905 | Study to Monitor the Effects of Androgen Suppression Treatment on the Heart(AST) | completed | Phase 4 | 181 | Ottawa Heart Institute Research CorporationOTHER | 1 | Apr 24, 2017 | clinicaltrials |
| NCT00470834 | Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy | completed | Phase 4 | 127 | GlaxoSmithKlineINDUSTRY | 2 | Feb 27, 2017 | clinicaltrials |
| NCT00171899 | Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML) | completed | Phase 4 | 80 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 23, 2017 | clinicaltrials |
| NCT02109289 | Etanercept in Rheumatoid Arthritis and Vascular Inflammation | terminated | Phase 4 | 5 | Innovaderm Research Inc.OTHER | 1 | Feb 7, 2017 | clinicaltrials |
| NCT01913990 | Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients.(ER11-02) | unknown | Phase 4 | 323 | Ottawa Hospital Research InstituteOTHER | 1 | Jan 30, 2017 | clinicaltrials |
| NCT00363311 | Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men | completed | Phase 4 | 302 | GlaxoSmithKlineINDUSTRY | 2 | Jan 18, 2017 | clinicaltrials |
| NCT03000114 | Collagenase Injection vs Percutaneous Needle Aponeurotomy for Dupuytren's Disease | unknown | Phase 4 | 334 | University of CalgaryOTHER | 1 | Dec 21, 2016 | clinicaltrials |
| NCT01468636 | A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts | terminated | Phase 4 | 50 | University of British ColumbiaOTHER | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01708850 | Study in Cancer Patients With Central Line Associated Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2) | completed | Phase 4 | 70 | London Health Sciences CentreOTHER | 1 | Sep 8, 2016 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials